Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Contraception. 2018 Feb 2;97(5):422–427. doi: 10.1016/j.contraception.2018.01.012

Figure 2.

Figure 2

Median concentration of Nestorone (NES) and estradiol (E2) observed for the main study cohort using contraceptive vaginal rings releasing 200 mcg NES with either 10, 20, or 40 mcg/day. Sampling occured twice weekly over the first 60 days of ring 1 and the last 30 days of ring 2. Breaks in lines indicates intervals of no data collection (days 61 – 83 and days 91 – 152).